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Nutritional Status and COPD
Anca Mihaela Hâncu, Florin Mihălțan, 
Mihaela Ionela Vladu and Maria Moța
Abstract
Since chronic obstructive pulmonary disease COPD and obesity became global 
public health challenges, the nutritional status evaluation is more important. How 
malnutrition and obesity will impact COPD prognosis and treatment is relevant and 
we considered need a separate approach. The new adiposity based chronic disease 
concept explains the role played by adiposity, and important studies, like European 
Community Health Survey ECRHS are highlighting the correlation between 
adiposity and lung function decline. On the other side, malnutrition decreases 
effort capacity and impairs the strength of respiratory muscles. Foods, nutrients 
and dietary patterns are influencing COPD prognosis and Mediterranean Diet, 
integrated in a healthy lifestyle should be part of COPD management. The impor-
tant benefic role played by fibers, whole grains, combined with anti-inflammatory 
and antioxidant effects of fruits and vegetables, together with poly-unsaturated 
fatty acids PUFA, fish, vitamins and minerals, is detailed below, in contrast with 
the detrimental role of Western Diet. A multidisciplinary approach in COPD should 
be considered, integrating lifestyle interventions as important tools in COPD 
management.
Keywords: obesity, lung function, malnutrition, COPD, nutritional intervention, 
lifestyle
1. Introduction
Nutritional status and chronic obstructive pulmonary disease COPD.
COPD definition & prevalence. A global public health challenge that can 
be prevented and treated, COPD is the 4th leading cause of death, estimated to 
become the 3rd. According to Global Initiative for Chronic Obstructive Lung 
Disease GOLD 2020, “COPD is a common, preventable and treatable disease that is 
characterized by persistent respiratory symptoms and airflow limitation that is due 
to airway and/or alveolar abnormalities usually caused by significant exposure to 
noxious particles or gases and influenced by host factors including abnormal lung 
development” [1].
Prevalence- Worldwide, COPD is underdiagnosed and under-recognized, with a 
medium of <6% of the adult population described in studies. However, most of the 
studies define COPD by spirometry, not combining symptoms, limiting prevalence 
description [1].
Nutritional status evaluation. Body mass index BMI (weight per square height) 
is not the only criteria which defines nutritional status, moreover other measure-
ments, like bioimpedance will describe better the muscle mass, lean mass and 
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adipose tissue. In COPD, the challenge will be to preserve, muscle mass, in order 
to support lung function. In scientific research dual energy X ray absorptiometry 
DXA, magnetic resonance imaging MRI are also used to evaluate body composition, 
but in daily clinical practice, bioimpedance is widely used.
Importance in COPD. Malnutrition, cachexia, obesity represent important  
co-morbidities, with impact on COPD evolution, treatment and mortality.
2. Obesity
Definition- Adiposity based chronic disease; Abdominal obesity. The con-
cept of cardiometabolic chronic disease, elaborated by Rippe [2] and Mechanick [3] 
some years ago gain more acceptance. It defines 4 stages: risk, pre-disease, disease 
and complications for 3 entities: Adiposity based chronic disease ABCD, dysglyce-
mic based chronic disease DBCD, cardiometabolic based chronic disease CMBCD. 
Practically, instead of obesity, a more complex approach is suggested, named 
ABCD. The risk stage combines genetics, environment with behavior. The second 
stage pre-disease describes the increased amount of adipose tissue with abnormal 
function and distribution. The third stage is classifying obesity based on BMI, with 
antropometrics and biochemical tests. The fourth stage is defining complications 
which are cardiometabolic and biomechanical. This more detailed approach is sug-
gesting better the multifactorial interdependence in obesity and the important role 
played by adiposity.
Prevalence. Worldwide, overweight prevalence is 39% and obesity 13%, 
meaning 650 mil obese people and 2 bil overweight [4] being an important health-
care issue. In order to better understand the impact of obesity on COPD evolution, 
analyzing actual studies results is important.
3. Lung function decline and obesity
3.1 European Community Respiratory Health Survey ECRHS
ECRHS is the longest prospective populational study, multicentric that involved 
18000 adults along 20 years in 3 phases [5]. Very detailed information have been 
obtained on forced vital capacity FVC, forced expiratory volume in first second 
FEV1 as lung function markers. Weight changes were considered as: moderate weight 
gain 0,25–1 kg/year; stable weight +/− 0,25 kg/year; weight loss −0,25 kg/year. As 
pulmonary disease diagnosis, asthma was noted. Records about lifestyle were avail-
able: smoking status, physical activity, leisure time. Results are summarized below in 
Table 1.
How these data may be interpreted? Weight gain is leading to an accelerated 
decline of FVC and FEV1, independent of initial weight, normal, overweight or 
underweight. Clinically, an accelerated decline of pulmonary function was noticed. 
FEV1/FVC ratio was not altered during weight gain, suggesting the possible restric-
tive syndrome associated with obesity. For underweight group, surprisingly, FEV1 
and FVC decline is attenuated, but the decline of FEV1/FVC ratio is accentuated, 
concluding that the airflow limitation typical for obstructive pulmonary syndrome 
may be favorized. Obese people who lost weight during the study period have an 
attenuated FVC and FEV1 decline suggesting the role played by obesity in the respi-
ratory function and the importance of including obese people in comprehensive 
lifestyle interventions for restoring a good pulmonary function.
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3.2 The Chinese study
A very large Chinese study included 452259 participants with diagnosed COPD, 
with a follow-up period of 10.1 years [6]. 10739 hospitalization events and deaths 
have been reported. The study concluded that underweight, with a BMI < 18,5 
represents an increased risk of COPD, adjusted hazard ratio HR 1.78 (95% CI, 
1.66–1.89). Abdominal obesity was positively associated with COPD risk, after 
adjustment for BMI. In conclusion, both, abdominal adiposity measures and BMI 
should be considered for COPD prevention.
3.3 Adipose tissue is not inert, but is acting like an endocrine organ
Adipose tissue may be considered a systemic modulator, influencing the 
response to environmental exposures and should be considered a potential target 
for future therapeutic interventions. As an endocrine organ, adipose tissue secretes 
adipokines, which are adipocyte derived factors that could affect airways func-
tion. Not only the inflammatory role recognized for leptin, but the anorexigenic 
role, accelerated metabolism, modulating immune function together with driving 
ventilatory regulation will influence pulmonary function [7, 8]. Leptin is sup-
posed to increase bronchial hyperreactivity [9] . In contrast, adiponectin is the 
anti-inflammatory adipokine, exclusively produced by adipocytes. In lean persons 
their activity is normal, but decrease in obese patients. Hypoxia, adipose tissue 
inflammation, macrophage infiltration in adipose tissue will induce finally insulin 
resistance [9].
3.4 Obesity paradox
Many years ago, in 2002 Gruberg used for the first time the term” obesity 
paradox” to characterize the lower risk of complications and mortality observed 
for overweight and obese people versus normal weight or underweight patients in 
coronary heart disease, pulmonary hypertension, heart failure, stroke, hyperten-
sion [10]. Not well elucidated, the concept of obesity paradox is still a subject for 
study. Increased risk of developing obesity is characterizing patients with COPD, 
since long term treatment with systemic glucocorticoids is administered [11] and 
usually a decreased physical activity is seen. Loss of free fat mass FFM, accompa-
nied by muscle weakness and exercise capacity decrease is seen in COPD patients, 
leading to the conclusion that FFM may be a better predictor than BMI. FFM and 
weight loss will impact prognosis in COPD [12]. Landbo, Jee [13, 14] described 
a lower mortality risk for COPD patients with higher BMI. Moreover, Cao [15] 
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described for underweight patients higher risk of mortality compared to leaner 
counterparts. (HR:0.78; 95% CI:0.65–0.94 and HR:0.69; 95% CI: 0.54–0.89). In this 
context, the importance of cardiorespiratory fitness CRF should not be neglected. 
Findings from Aerobic Center Longitudinal Study proved that CRF modify the 
association between adiposity and results on survival. Fogelholm [16] found a 
lower all cause/cardiovascular CVD mortality risk for individuals with high BMI 
and improved aerobic capacity, but this protective effect disappear for BMI > 35 kg/
m2. In a study concluded by Sabino [17] for 32 patients with COPD, higher FFM 
and exercise capacity lead to better functional outcomes for overweight and obese 
patients. Practically, obesity paradox is mainly related to CRF and FFM. The role of 
physical activity PA is well proved in type 2 diabetes, CVD but not well documented 
in COPD, suggesting potential future correlations and research PA-obesity paradox-
CRF and COPD.
In COPD, considering obesity paradox, a question arise: To treat or not to 
treat? Best strategy is under research, clinicians dilemma is to recommend weight 
reduction which will improve cardiac performance but may worsen respiratory 
performance and increase mortality? Which could be the ideal intervention to loose 
weight? [18].
A new study published in 2020 may propose new answers [19]. The relation-
ship between exacerbation frequency in COPD should be investigated in detail 
in order to understand better the obesity paradox [20, 21]. This is an observa-
tional, retrospective study performed in Netherlands [19] that included 604 
patients with COPD, stratified based on BMI level. Lowest five year survival 
rate was found for underweight and normal weight patients (35%, 41%, p = NS 
not significant). Survival increased at 47% (p = 0.028) for overweight group, 
51% (p = 0.046%) for moderately obese and 63% for severely obese (p = 0.003) 
patients, versus normal weight patients. Cox regression analysis showed that the 
effect was independent by other variables and HR = 0.962 (95% CI 0.940–0.984) 
p = 0.001. The study demonstrated a significant reduction in the exacerbation 
frequency that required hospitalization in obese patients. Moreover, a significant 
decrease by 34–40% of readmissions for obese patients was noticed together with 
a decreased mortality. In contrast with other studies, were the” protective” effect 
was lost for BMI > 32 kg/m2, in this study, the group with BMI > 35 kg/m2 was 
more protected. The fact that cardiovascular comorbidities, atherosclerosis, is 
causing a higher mortality rate for leaner patients with COPD should be discussed 
[22]. Fat reserve, offering a protective source of energy along hospitalization in 
critical illness should be considered, too. This is supported by better survival rate 
for critically ill patients with a higher BMI [23, 24]. Preserved muscle mass mean a 
better prognosis influencing stroke volume and cardiac output [25]. Furthermore, 
lower systemic vascular resistance is described for obese patients. On the other 
side, underweight patients, in this study, had an increased mortality, attributed 
to decreased CRF in the context of lower muscle mass, decreased cardiac output 
and limited energy storage [23, 24]. Underweight is associated with an increased 
readmission time in this study, in line with previous data about malnourished 
patients. How the results of this study should be interpreted? They are limited to 
specific groups of patients suffering from a disease and should not be considered 
guidelines for preventive measures at populational level, as authors are mention-
ing. But, best explanation of this paradox will help the specific approach for 
future interventions. In conclusion, exacerbation frequency reduction in obese 
patients with COPD may partially explain obesity paradox, but more prospective 
research is needed.
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Malnutrition is represented in COPD with a prevalence of 30–60% [26]. Daily 
energetic expense with respiratory effort is 36–72 kcal/day, normally, but this value 
may increase by 10 times in COPD. Malnutrition is produced by increased basal 
metabolic rate, low nutritional intake, or both. The energy spent may be increased 
more by infections associated with fever.
4.2 The diagnosis of malnutrition
The diagnosis of malnutrition will be based on Global Leadership Initiative on 
Malnutrition GLIM [27] criteria for the Diagnosis of Malnutrition: a consensus 
report from the Global Clinical Nutrition Community. There are described 3 
phenotypic criteria: low BMI, decrease intake or assimilation of food, unintentional 
weight loss; and 2 etiologic criteria: disease severity, inflammation and muscle 
mass decrease. For diagnosis, one etiologic and one phenotypic criteria will be 
mandatory.
Being an unfavorable prognosis in COPD, malnutrition predispose to infections, 
lead to weight decrease, decrease effort capacity and the strength of respiratory 
muscles. Moreover infections decrease surfactant production.
Issues to be addressed in COPD: loss of muscle mass is a strong negative progno-
sis factor, as has been discussed in previous paragraph and should be addressed by a 
correct medical nutrition therapy that will be detailed later in this chapter.
5.  Lung function and individual foods and nutrients in the context of 
COPD
5.1 Fibers and whole grains
Larger research focused on wholegrain has been done in relation with cardiovas-
cular disease CVD and cancer [28], but independent benefits have been reported 
in observational studies on lung function [29, 30] and COPD. Synergic effects 
of phenolic acids, phytic acid, selenium, vitamin E, essential fatty acids, found 
in whole grains explain documented benefits on respiratory disease, observed in 
nonrespiratory diseases, too. Large prospective studies [31] revealed a 40% reduc-
tion in the COPD risk after higher fiber intake. Epidemiological data associated 
fiber intake with lower serum levels of C reactive protein and cytokines (interleukin 
IL 6, tumoral necrosis factor TNF) and high adiponectine levels, with well-known 
anti-inflammatory effect. Protective effects are seen mainly for cereal fiber intake 
in current smokers and ex-smokers, but fruits and vegetable fibers are evidenced, 
too [31, 32].
5.2 Antioxidant and anti-inflammatory foods - fruits and vegetables
The inflammatory/oxidative pathogenetic implications in COPD, as well as 
nutritional status and the dietary quality in COPD lead to verify the relations 
between respiratory effects of antioxidants and anti-inflammatory dietary compo-
nents. In 2 recent Swedish populational studies, beneficial role of high consumption 
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of fruits and vegetables on long term was reflected in a decreased incidence of 
COPD, 35% decreased risk in men (p < 0,0001) and 37% lower risk for women 
(p < 0,0001) consecutive high consumption of fruits (boths) and vegetables (men). 
This benefit was mainly obvious in smokers [33, 34]. In conclusion fresh, hard 
fruits and vegetables provide benefits on lung function decline, COPD symptoms, 
COPD incidence and mortality. Specific, the protective effect in the men cohort 
was limited to current smokers or ex-smokers, explained probably by increased 
antioxidative stress level in smoking. Individual food items observed: apples, pears, 
peppers, green leafy vegetables [33].
5.3 Vitamins
Limited evidence is reported about any benefit of vitamin D supplementation in 
COPD progression and immune responses. A conclusion can be drawn, for patients 
with baseline low level of (OH) D < 25 nmol/L supplementation is beneficial in 
preventing COPD exacerbations [35]. There are described genetic mutations of vit 
D binding protein associated with decreased vit D levels linked with a higher risk 
of COPD [36]. Conflicting results are reported with vit D supplementation but in 
conclusion they pointed out a benefit for patients with low baseline levels of (OH) 
D < 25 nmol/L, the active metabolite of vitamin D [37]. The antioxidative effect of 
vitamin E is revealing promising options for lung function decline associated with 
age. Well recognized action for vitamin C, which protects lung tissue, focusing on 
lung function maintenance mediated by vitamin C may lead to a greater success in 
exploring potential targets in preventing pulmonary diseases [38].
5.4 Minerals
Intake of calcium, phosphorus, potassium, iron and selenium are positively 
associated with lung function measures (measured by FEV1) based on a case 
control study published in Japan. 35% reduction of COPD risk is inversely cor-
related with Calcium intake [39]. An independent positive correlation is found 
between FEV1 and selenium, calcium, iron and chloride but inverse correlation 
with sodium and potassium in the general population [40]. Cooper and selenium 
serum levels are also related to higher lung function in other cross-sectional studies 
[41]. Through its protective effect against bronchoconstriction and inflammation, 
Magnesium may play a beneficial role in pulmonary function [42]. Further studies 
are warranted to prove protective effects of some minerals, explained mainly by 
antioxidant and anti-inflammatory properties.
5.5 Polyunsaturated fatty acids & fish
Higher intake of ω3-PUFA is related to lower levels of cytokine TNF (OR = 0.46, 
p = 0.049) in stable patients with COPD. The same study mentioned the association 
between a high intake of ω 6-PUFA with high inflammatory markers, for example 
C reactive protein CRP, interleukin 6, IL6. (OR = 1.96 for IL-6, p = 0.034; for CRP 
OR = 1.95, p = 0.039) [43]. Lower FEV1 after higher consumption of ω6-PUFA was 
evidenced in a large population based cross sectional study, mainly in smokers, with 
a higher risk of COPD but without relation to ω3-PUFA [44]. Potential fish benefits 
in the diet might be obvious within the whole diet, as a recent analysis of two large 
cohorts is suggesting [45]. 4 servings of fish/week were associated with lower risk 
of newly diagnosed COPD in 2 large US cohorts. A healthy diet including fish and 
vegetable sources of ω3-PUFA may be beneficial for COPD, as fish intake could 
reduce the risk of COPD when plant sources of ω3-PUFA intake is high.
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5.6 Foods with negative effects on lung function and COPD
A cross sectional analysis of NHNES [46] associated independently an obstruc-
tive pattern in spirometry with increased intake of cured meat but also with newly 
diagnosed COPD patients, independently of Western dietary pattern or other asso-
ciations [46, 47]. A more recent large populational study from Sweden confirmed 
the detrimental effect of processed red meat [48, 49] but not unprocessed. Another 
reference showed an increased risk of readmission from COPD associated with 
cured meat intake. A meta-analysis, recently summarized results indicating that 
higher consumption of red processed meat (more than 75-785 g/week) is leading to 
a 40% increased risk of COPD [50, 51].
6. Dietary patterns and COPD
In COPD pathogenesis, pollution, genetics, smoking, aging, play a role in 
developing inflammation, oxidative stress, mucus hypersecretion, antioxidant 
Figure 1. 
Food pyramid for subjects with COPD.
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depletion, airway remodeling [28] . But lung function is influenced by dietary 
factors, too. Detrimental role for lung function of Western type diet, characterized 
by high energy dense food, red and processed food, added sugar, high salt intake, 
preservatives, low antioxidants, high glycemic index and saturated fats is already 
proven. By contrast, fruits, vegetables, whole grains, alcohol, wine, legumes, nuts, 
coffee, fish, high antioxidants, low glycemic index and unsaturated fats, as part of a 
mediterranean healthy pattern are a support of a healthy lung function. As dietary 
patterns, is clearly proved the detrimental role of Western model and the protective 
role of Mediterranean model in COPD.
A special pyramid was designed for COPD patients, represented below, in 
Figure 1, adapted after International Journal of COPD, 2020 [52].
7. Medical nutrition therapy MNT in COPD
Daily energy has to be adapted to activities and requirements calculated by bio-
impedance and calorimetry in order to maintain BMI below 30–32 kg/m2. (special situ-
ation in malnutrition is detailed separately). Recommended macronutrients proportion 
is: 15–25% proteins, 30–45% fats, 40–55% carbohydrates. It has to be underlined 
that the % of macronutrients is important to maintain (respiratory quotient)RQ, the 
marker for respiratory tolerance of the pattern recommended. Respiratory quotient, 
defined as CO2 volume expired/O2 volume consumed is the respiratory parameter that 
indicates food mix metabolized. RQ is 1 for carbohydrates, 0.85 in mixed diets, 0,82 
for proteins and 0.7 for fat. The macronutrient percentage is important, correct diet, 
but not overconsumption will be critical for COPD patients which have compromised 
ability for gas exchanges, because excess calories produce CO2 that must be expired and 
will influence the respiratory process [26]. Considering drug-food interactions, special 
attention should be considered for salt intake during oral corticosteroid treatment, 
that should be minimized. Meanwhile, due to increased risk for metabolic disorders, 
especially high glycaemia, sugar intake should be limited [26].
7.1 MNT in obesity
Muscle mass decrease is a risk factor for mortality from COPD and muscle mass 
maintenance is important. Considering these, the recommended daily protein 
intake is 1,2–1,5 g/kgb/day, combined with physical exercises, much more compared 
to general population recommendations of 0.75–1 g/kgb/day [53]. General recom-
mendations, specified in the 2019 obesity guidelines [54] should be emphasized: 
decreasing food energetic density, avoid skipping meals, but also snacking, eating 
just as response to hunger sensations and stop eating when satiety appears, eating 
slowly and mindfully, as an assumed responsibility, not as a restriction.
7.2 MNT in malnutrition
the objective is to address hypermetabolism in order to prevent weight decrease 
and lean mass decrease. Practically lean mass/muscular mass maintenance is the 
key for a good prognosis in COPD [26]. From clinician perspective, MNT should 
address appetite decrease and improper food intake. Main recommendations are: 
small meals, frequent, nutritional dense. The main meal should be at the time 
when the energetic level is the highest. It is recommended to rest before meal. The 
proper caloric intake will be adjusted in order to maintain a BMI of 20–24 kg/m2. 
Availability of food which request minimum time to be prepared, eventually pre-
prepared is important. To limit alcohol intake <2 portions/day, 30 g is mandatory.
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8. Lifestyle recommendations in COPD
All these nutritional recommendations should be integrated in a healthy life-
style. Mandatory tobacco cessation, gradual increase in physical activity, accord-
ing to cardiorespiratory fitness score, optimal sleep and mindfulness, seen as a 
harmony between mind, body, thoughts and feelings will be beneficial for COPD 
patients. Despite a great interest in managing COPD, there is a gap in recommenda-
tions for physical activity (PA), the most commonly prescribed PA is: walking, 
cycling, strength training and nonspecific aerobic training. Physical activity PA 
should be part of lifestyle, may be performed in groups, social or independently. 
People with COPD should be active until breathless or as per their capacity. 
Recommended PA durations are ranging from 20 to 45 min/day, depending on 
guideline. For severe patients, to add short intervals rather than a continuous 
activity is mentioned. No specific guidelines are mentioning sedentary behaviors. 
Despite the fact that no specific sleep recommendations are in COPD guidelines, we 
encourage a referral to a sleep specialist [55].
9. Post-COVID 19
Post COVID 19 pulmonary rehabilitation measures, which start in the hospital 
for moderate cases, will improve symptoms like dyspnea, anxiety, depression and 
should continue as part of a healthy lifestyle after recovery, for future. A healthy 
lifestyle, normalizing body weight by adopting a healthy model adapted to caloric 
and nutritive requirements daily physical activity and an optimal sleep, mindful-
ness, will remain key principles for COPD patients after SARS-COV2 infection.
10. Conclusion
New concept of cardiometabolic disease reflects in a more appropriate way 
the role of adipose tissue in all comorbidities developed in obesity. Lung function 
decline associated with obesity, as it is revealed by important studies may be an 
interesting relation to be considered in COPD obese patients. Moreover, malnu-
trition, with the worst prognosis on COPD development will influence patients 
management. The importance of a healthy dietary pattern in COPD, designed in the 
new COPD pyramid are suggesting the strong correlation between foods, nutrients 
in order to achieve best therapeutical results. Medical nutrition therapy in COPD, 
based on Mediterranean model, with a high % of proteins, integrated in a healthy 
lifestyle should be part of COPD management. Nutritional status play an important 
role in future COPD prognosis and a multidisciplinary team with pneumologist, 
nutritionist and kinetotherapist should cooperate in order to achieve best long term 
outcomes.
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